Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis.
Carragee EJ, Chu G, Rohatgi R, Hurwitz EL, Weiner BK, Yoon ST, Comer G, Kopjar B. Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis. J Bone Joint Surg Am. 2013 Sep 04; 95(17):1537-45.